January 01, 21 - 5:40 pm - LABS

Pfizer requests emergency use for its vaccine in Colombia

On Thursday, the pharmaceutical company Pfizer filed with the Colombian National Institute for Food and Drug Surveillance (Invima) the license request for emergency use of the vaccine against COVID-19.

The country’s agency has a maximum of 10 business days to provide a substantive statement. According to El Tiempo, Pfizer has already presented the documents required, which was issued for the first time to grant permits for vaccines and drugs in advanced experimentation stages.

On Wednesday, Colombia’s President Iván Duque announced in his daily broadcast on Wednesday that the National Government closed an agreement with the pharmaceutical company Janssen, a Johnson & Johnson subsidiary, to purchase 9 million vaccines against COVID-19. With this new figure, the country will be able to vaccinate 29 million Colombians in 2021.